The role of regulatory policies on unhealthy commodities to prevent and control noncommunicable diseases in the Americas
The growing burden of noncommunicable diseases (NCDs) cannot be addressed through clinical interventions alone. Population-level regulatory interventions—such as fiscal measures, marketing restrictions, and labeling regulations—are central to effective NCD prevention and control. This article addresses the role of regulatory policies in preventing NCDs, with a focus on progress and implementation gaps in the Americas.

